Zullo Investment Group’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $301K | Sell |
677
-126
| -16% | -$56.1K | 0.12% | 122 |
|
|
2025
Q1 | $389K | Buy |
803
+1
| +0.1% | +$485 | 0.17% | 100 |
|
|
2024
Q4 | $323K | Buy |
802
+50
| +7% | +$20.1K | 0.13% | 113 |
|
|
2024
Q3 | $350K | Sell |
752
-28
| -4% | -$13K | 0.15% | 107 |
|
|
2024
Q2 | $366K | Sell |
780
-14
| -2% | -$6.56K | 0.16% | 105 |
|
|
2024
Q1 | $332K | Buy |
794
+10
| +1% | +$4.18K | 0.16% | 109 |
|
|
2023
Q4 | $319K | Buy |
784
+1
| +0.1% | +$407 | 0.16% | 110 |
|
|
2023
Q3 | $272K | Hold |
783
| – | – | 0.16% | 112 |
|
|
2023
Q2 | $276K | Hold |
783
| – | – | 0.16% | 113 |
|
|
2023
Q1 | $247K | Sell |
783
-35
| -4% | -$11K | 0.15% | 117 |
|
|
2022
Q4 | $236K | Sell |
818
-53
| -6% | -$15.3K | 0.14% | 117 |
|
|
2022
Q3 | $252K | Sell |
871
-66
| -7% | -$19.1K | 0.16% | 110 |
|
|
2022
Q2 | $264K | Sell |
937
-13
| -1% | -$3.66K | 0.17% | 110 |
|
|
2022
Q1 | $248K | Sell |
950
-27
| -3% | -$7.05K | 0.13% | 133 |
|
|
2021
Q4 | $215K | Buy |
+977
| New | +$215K | 0.11% | 154 |
|